Skip to main content

CASTLE BIOSCIENCES INC

For the period ended May 28, 2026. Filed Apr 8, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 28, 2026 · Filed Apr 8, 2026

CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

VOTING MATTERS

Please read this Proxy Statement for the 2026 annual meeting of stockholders (including any adjournments, continuations or postponements thereof) of Castle Biosciences, Inc., a Delaware corporation and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, before voting on the following matters:

Proposals · Board Vote Recommendation · Page Reference (for more detail)
1Election of Three Class I DirectorsFOR ALL9
2Ratification of Independent AuditorFOR36
3Advisory Approval of Executive Compensation (Say-on-Pay)FOR39
4To approve the Company’s non-employee director compensation policy.FOR41
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.